04180nam 22007935 450 991072839690332120230526160317.09783031295416(electronic bk.)978303129540910.1007/978-3-031-29541-6(MiAaPQ)EBC30552979(Au-PeEL)EBL30552979(OCoLC)1380875404(DE-He213)978-3-031-29541-6(BIP)089067678(PPN)270616381(CKB)26784778600041(EXLCZ)992678477860004120230526d2023 u| 0engurcnu||||||||txtrdacontentcrdamediacrrdacarrierAdvances in Pharmacokinetics and Pharmacodynamics /edited by Panos Macheras1st ed. 2023.Cham :Springer International Publishing :Imprint: Springer,2023.1 online resource (208 pages)AAPS Introductions in the Pharmaceutical Sciences,2522-8358 ;9Print version: Macheras, Panos Advances in Pharmacokinetics and Pharmacodynamics Cham : Springer International Publishing AG,c2023 9783031295409 Pharmacokinetics -- Chapter 1: Current status in PBPK modeling -- Chapter 2: Physiologically based biopharmaceutics modeling (PBBM) Application on Food Effect Assessment -- Chapter 3: Physiologically based finite time pharmacokinetic (PBFTPK) models: Inception and development -- Chapter 4: Physiologically based finite time pharmacokinetic (PBFTPK) models: Applications -- Pharmacodynamics -- Chapter 5: Pharmacokinetic – Pharmacodynamic Modelling and Simulation in Clinical Practice and Studies -- Chapter 6: On the Verge of Impossibility: Accounting for Variability Arising from Permutations of Comorbidities that Affect the Fate of Drugs in the Human Body -- Chapter 7: Impact of Clinical Pharmacology on the Modernization of Drug Development and Regulation.This book provides a concise overview of recent advances in Pharmacokinetics (PK) and Pharmacodynamics (PD). The pharmacokinetics section covers the state of the art in Physiologically Based Pharmacokinetic (PBPK) modeling (Chapter 1) as well as the assessment of food effect on drug absorption using PBPK modeling (Chapter 2). Chapters 3 and 4 describe the recent development of Physiologically Based Finite Time Pharmacokinetic (PBFTPK) models and their applications to pharmacokinetic data. The pharmacodynamics section focuses on PK/PD modeling. Chapter 5 provides an overview of PK/PD modeling and simulation in clinical practice and studies. Chapter 6 deals with the subject/physiology variability issue encountered in PK/PD studies, while Chapter 7 reviews the influence of clinical pharmacology in the modernization of drug development and regulation. This book is an essential reference for pharmaceutical scientists.AAPS Introductions in the Pharmaceutical Sciences,2522-8358 ;9Drug delivery systemsDrugs—DesignPharmaceutical chemistryMetabolismPharmacologyClinical biochemistryDrug DeliveryStructure-Based Drug DesignPharmaceuticsMetabolismPharmacologyMedical BiochemistryTherapeuticsMedicalDrug delivery systems.Drugs—Design.Pharmaceutical chemistry.Metabolism.Pharmacology.Clinical biochemistry.Drug Delivery.Structure-Based Drug Design.Pharmaceutics.Metabolism.Pharmacology.Medical Biochemistry.615.7615.7Macheras Panos755977Macheras PanosothMiAaPQMiAaPQMiAaPQ9910728396903321Advances in Pharmacokinetics and Pharmacodynamics3379512UNINA